Get the content you want anytime you want.
REGISTER NOW | SIGN IN
VIDEO

Rutgers Researchers Develop New MRSA Prodrug: Can the Pathogen Gain Resistance?

AUG 16, 2017 | CONTAGION® EDITORIAL STAFF


Daniel Pilch, PhD, associate professor in the Department of Pharmacology at Rutgers Robert Wood Johnson Medical School, co-founder of TAXIS Pharmaceuticals, breaks down the process of how Staphylococcus aureus (S. aureus) is able to gain resistance to methicillin. Dr. Pilch also explains if the pathogen can gain resistance to a new prodrug he helped develop: TXA709. 
To stay informed on the latest in infectious disease news and developments, please sign up for our weekly newsletter.


FEATURED
We break down our top HIV news stories of 2017. Did you read them all?
x